Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Rapamycin for Fibrofolliculomas in BHD
NCT00928798Phase 3Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Jan 2010
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sirolimus in Birt-Hogg-Dubé syndrome (BHDS), sponsored by Maastricht University Medical Center+. Started Jan 2010; status: completed.
02
Drugs
sirolimus
03
Conditions
Birt-Hogg-Dubé syndrome (BHDS)
Beyond the preview
Go deeper on NCT00928798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00928798.